Bio-Techne Unveils Next-Gen Leo System for High-Throughput Protein Analysis
Bio-Techne Corporation has recently launched its next-generation Leo™ System, representing a significant advancement in the realm of high-throughput protein analysis. This innovative system incorporates dual-channel fluorescence detection alongside traditional chemiluminescence, marking a pivotal enhancement designed to optimize data throughput and efficiency while providing deeper insights into precious biological samples.
With the ability to detect a remarkable number of targets—up to 24 per sample—this new system facilitates a more versatile approach to experimental design. The integration of fluorescence detection introduces an additional multiplexing option to the existing capabilities of molecular weight separation, RePlex, and resampling. This level of flexibility empowers researchers to explore complex biological questions with ease and precision.
The Leo System enhances experimental throughput, allowing scientists to analyze up to 100 capillaries within a three-hour window, thereby maximizing productivity without compromising data quality. Furthermore, the ability to simultaneously quantify biomolecules with varying expression levels and to assess different proteoforms—including phosphorylated and total protein forms—within a single capillary greatly expands the potential applications of the technology.
Dr. Alexandre Lucas from the French National Institute of Health and Medical Research expressed enthusiasm for the system's capabilities, noting its high-precision outcomes and minimal variability, crucial in today's competitive research landscape. "Leo represents the future of clinical research requiring absolute quantitation with exceptional accuracy," Dr. Lucas stated. Indeed, with an impressive variability rate of just 5–6%, the Leo System sets a benchmark for reliability in protein analysis.
Will Geist, President of Bio-Techne’s Protein Sciences Segment, emphasized the transformative impact of the next-generation Leo System: "This launch is crucial for our clients, as it provides unparalleled precision and efficiency in protein analysis. Our advanced detection technologies, combined with built-in compliance features, are designed to help researchers achieve quicker and more dependable results, thereby expediting vital discoveries and streamlining development processes."
As Bio-Techne continues to solidify its leadership in proteomic analytical instruments, the Leo system underscores its commitment to advanced life science research. Interested parties can explore the enhanced functionality of the Leo System, particularly its new fluorescence-based detection options, by visiting bio-techne.com/leo.
With a robust portfolio of innovative tools and bioactive reagents, Bio-Techne plays a significant role in supporting scientific inquiries into biological processes, the understanding of various diseases, and advancements in drug discovery. The company reported over $1.2 billion in net sales in the last fiscal year, with approximately 3,100 employees committed to improving healthcare outcomes worldwide. For those seeking further information about Bio-Techne and its comprehensive product offerings, an online presence is maintained across major social media platforms, including LinkedIn, X, and YouTube.
With the ability to detect a remarkable number of targets—up to 24 per sample—this new system facilitates a more versatile approach to experimental design. The integration of fluorescence detection introduces an additional multiplexing option to the existing capabilities of molecular weight separation, RePlex, and resampling. This level of flexibility empowers researchers to explore complex biological questions with ease and precision.
The Leo System enhances experimental throughput, allowing scientists to analyze up to 100 capillaries within a three-hour window, thereby maximizing productivity without compromising data quality. Furthermore, the ability to simultaneously quantify biomolecules with varying expression levels and to assess different proteoforms—including phosphorylated and total protein forms—within a single capillary greatly expands the potential applications of the technology.
Dr. Alexandre Lucas from the French National Institute of Health and Medical Research expressed enthusiasm for the system's capabilities, noting its high-precision outcomes and minimal variability, crucial in today's competitive research landscape. "Leo represents the future of clinical research requiring absolute quantitation with exceptional accuracy," Dr. Lucas stated. Indeed, with an impressive variability rate of just 5–6%, the Leo System sets a benchmark for reliability in protein analysis.
Will Geist, President of Bio-Techne’s Protein Sciences Segment, emphasized the transformative impact of the next-generation Leo System: "This launch is crucial for our clients, as it provides unparalleled precision and efficiency in protein analysis. Our advanced detection technologies, combined with built-in compliance features, are designed to help researchers achieve quicker and more dependable results, thereby expediting vital discoveries and streamlining development processes."
As Bio-Techne continues to solidify its leadership in proteomic analytical instruments, the Leo system underscores its commitment to advanced life science research. Interested parties can explore the enhanced functionality of the Leo System, particularly its new fluorescence-based detection options, by visiting bio-techne.com/leo.
With a robust portfolio of innovative tools and bioactive reagents, Bio-Techne plays a significant role in supporting scientific inquiries into biological processes, the understanding of various diseases, and advancements in drug discovery. The company reported over $1.2 billion in net sales in the last fiscal year, with approximately 3,100 employees committed to improving healthcare outcomes worldwide. For those seeking further information about Bio-Techne and its comprehensive product offerings, an online presence is maintained across major social media platforms, including LinkedIn, X, and YouTube.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.